The role of pharmacists in improving access to safe and quality essential medicines and medical devices is the focus of a new reference document published by FIP today.

The publication contains case studies from Australia, Egypt, Malaysia, the Netherlands, South Africa and Spain, presenting the current situation of access to essential medicines, including related regulations and impact of pharmacists in each country. It also looks at capacity building for improved access to pharmaceutical expertise, including new roles for pharmacists in light of developments in public health and technology.

“Essential Medicines Lists serve as a foundation for promoting equitable access to healthcare and addressing the most pressing health needs within a population. This document highlights the importance of access to essential medicines. It also outlines the role of FIP in improving access and addressing the challenges and issues that exist around it. Access to medicines is integral to achieving universal health coverage. This document can be used as an advocacy tool for overcoming barriers hindering access,” said Lars-Åke Söderlund, FIP vice president and co-chair of the FIP committee that developed the reference document.